| VEGF-A drives TOX-dependent T cell exhaustion in anti–PD-1–resistant microsatellite stable colorectal cancers CG Kim, M Jang, Y Kim, G Leem, KH Kim, H Lee, TS Kim, SJ Choi, ... Science immunology 4 (41), eaay0555, 2019 | 176 | 2019 |
| Human liver CD8+ MAIT cells exert TCR/MR1-independent innate-like cytotoxicity in response to IL-15 MS Rha, JW Han, JH Kim, JY Koh, HJ Park, SI Kim, MS Kim, JG Lee, ... Journal of Hepatology 73 (3), 640-650, 2020 | 52 | 2020 |
| PD-1 blockade-unresponsive human tumor-infiltrating CD8+ T cells are marked by loss of CD28 expression and rescued by IL-15 KH Kim, HK Kim, HD Kim, CG Kim, H Lee, JW Han, SJ Choi, S Jeong, ... Cellular & Molecular Immunology 18 (2), 385-397, 2021 | 51 | 2021 |
| Functions of human liver CD69+ CD103-CD8+ T cells depend on HIF-2α activity in healthy and pathologic livers JH Kim, JW Han, YJ Choi, MS Rha, JY Koh, KH Kim, CG Kim, YJ Lee, ... Journal of Hepatology 72 (6), 1170-1181, 2020 | 49 | 2020 |
| A comparative study of sorafenib and metronomic chemotherapy for Barcelona Clinic Liver Cancer-stage C hepatocellular carcinoma with poor liver function H Yang, HY Woo, SK Lee, JW Han, B Jang, HC Nam, HL Lee, SW Lee, ... Clinical and Molecular Hepatology 23 (2), 128, 2017 | 36 | 2017 |
| Early reduction of regulatory T cells is associated with acute rejection in liver transplantation under tacrolimus-based immunosuppression with basiliximab induction JW Han, DJ Joo, JH Kim, MS Rha, JY Koh, HJ Park, JG Lee, MS Kim, ... American Journal of Transplantation 20 (8), 2058-2069, 2020 | 31 | 2020 |
| Immune responses following locoregional treatment for hepatocellular carcinoma: possible roles of adjuvant immunotherapy JW Han, SK Yoon Pharmaceutics 13 (9), 1387, 2021 | 23 | 2021 |
| Distinct Patterns of HBV Integration and TERT Alterations between in Tumor and Non-Tumor Tissue in Patients with Hepatocellular Carcinoma JW Jang, HS Kim, JS Kim, SK Lee, JW Han, PS Sung, SH Bae, JY Choi, ... International journal of molecular sciences 22 (13), 7056, 2021 | 23 | 2021 |
| IFNL3-adjuvanted HCV DNA vaccine reduces regulatory T cell frequency and increases virus-specific T cell responses JW Han, PS Sung, SH Hong, H Lee, JY Koh, H Lee, S White, JN Maslow, ... Journal of Hepatology 73 (1), 72-83, 2020 | 21 | 2020 |
| Association between serum tumor necrosis factor-α and sarcopenia in liver cirrhosis JW Han, DI Kim, HC Nam, U Im Chang, JM Yang Clinical and Molecular Hepatology 28 (2), 219, 2022 | 18 | 2022 |
| Ex vivo Detection and Characterization of Hepatitis B Virus-Specific CD8+ T Cells in Patients Considered Immune Tolerant PS Sung, DJ Park, JH Kim, JW Han, EB Lee, GW Lee, HC Nam, JW Jang, ... Frontiers in Immunology 10, 1319, 2019 | 18 | 2019 |
| Risk factors and outcomes of hepatitis B virus reactivation in hepatitis B surface antigen negative patients with hematological malignancies JW Han, H Yang, HL Lee, SH Bae, JY Choi, JW Lee, HJ Kim, S Lee, ... Hepatology Research 46 (7), 657-668, 2016 | 18 | 2016 |
| Comparative analysis of lenvatinib and hepatic arterial infusion chemotherapy in unresectable hepatocellular carcinoma: a multi-center, propensity score study J Lee, JW Han, PS Sung, SK Lee, H Yang, HC Nam, SH Yoo, HL Lee, ... Journal of Clinical Medicine 10 (18), 4045, 2021 | 17 | 2021 |
| Identification of a distinct NK-like hepatic T-cell population activated by NKG2C in a TCR-independent manner JY Koh, MS Rha, SJ Choi, HS Lee, JW Han, H Nam, DU Kim, JG Lee, ... Journal of Hepatology 77 (4), 1059-1070, 2022 | 16 | 2022 |
| Dynamic changes in ex vivo T-cell function after viral clearance in chronic HCV infection JW Han, PS Sung, KH Kim, SH Hong, EC Shin, M Jun Song, SH Park The Journal of Infectious Diseases 220 (8), 1290-1301, 2019 | 14 | 2019 |
| Early hepatitis B surface antigen seroclearance following antiviral treatment in patients with reactivation of resolved hepatitis B HL Lee, JW Jang, JW Han, SW Lee, SH Bae, JY Choi, NI Han, SK Yoon, ... Digestive Diseases and Sciences 64, 2992-3000, 2019 | 12 | 2019 |
| Hemorheological alteration in patients clinically diagnosed with chronic liver diseases B Jang, JW Han, PS Sung, JW Jang, SH Bae, JY Choi, YI Cho, SK Yoon Journal of Korean medical science 31 (12), 1943-1948, 2016 | 11 | 2016 |
| Predicting outcomes of atezolizumab and bevacizumab treatment in patients with hepatocellular carcinoma JW Han, JW Jang International Journal of Molecular Sciences 24 (14), 11799, 2023 | 10 | 2023 |
| Whole blood viscosity is associated with extrahepatic metastases and survival in patients with hepatocellular carcinoma JW Han, PS Sung, JW Jang, JY Choi, SK Yoon PloS one 16 (12), e0260311, 2021 | 9 | 2021 |
| Tissue-resident lymphocytes: implications in immunotherapy for hepatocellular carcinoma JW Han, SK Yoon International Journal of Molecular Sciences 22 (1), 232, 2020 | 7 | 2020 |
